×
About 12,855 results

ALLMedicine™ Botulinum Toxin Center

Research & Reviews  3,966 results

A Study of Combination Unilateral Subcutaneous Botulinum Toxin A Treatment for Androgen...
https://doi.org/10.1111/jocd.15179
Journal of Cosmetic Dermatology; Tian K, Gao S et. al.

Jun 26th, 2022 - To observe the efficacy of unilateral subcutaneous injection of botulinum toxin A combined with finasteride and minoxidil in the treatment of androgenic alopecia. Thirty-seven patients with androgenic alopecia were treated with finasteride and min...

Reduction of neuronal hyperexcitability with modulation of T-type calcium channel or SK...
https://doi.org/10.1016/bs.irn.2022.02.008
International Review of Neurobiology; Wagle Shukla A

Jun 25th, 2022 - Essential tremor is one of the most prevalent movement disorders. Propranolol and primidone are the first-line pharmacological therapies. They provide symptomatic control in less than 50% of patients. Topiramate, alprazolam, clonazepam, gabapentin...

Intra-muscular Botulinum Toxin A in Chronic Athletic Pubalgia: a Retrospective Observational Study
https://clinicaltrials.gov/ct2/show/NCT05430893

Jun 24th, 2022 - The investigators included consecutive individuals with chronic athletic pubalgia for whom medical and/or surgical treatments have failed and who were treated with an intra-muscular injection of botulinum toxin A under ultrasound guidance. Partici...

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
https://clinicaltrials.gov/ct2/show/NCT05248867

Jun 24th, 2022 - Facial lines that develop from repeated facial expression, such as glabellar lines (GL), are typically treated by selectively weakening specific muscles with small quantities of botulinum toxin. AGN-151586 is an investigational product being devel...

Botulinum Toxin for the Treatment of Involuntary Movement Disorders
https://clinicaltrials.gov/ct2/show/NCT00001208

Jun 24th, 2022 - The efficacy of botulinum toxin (BTX) has now been demonstrated for a variety of diseases associated with involuntary muscles spasms or movement. The application of botulinum toxin therapy to movement disorders requires treatment tailored to the i...

see more →

Guidelines  10 results

Clinical Practice Guideline: Hoarseness (Dysphonia) (Update).
https://doi.org/10.1177/0194599817751030
Otolaryngology--head and Neck Surgery : Official Journal ... Stachler RJ, Francis DO et. al.

Mar 2nd, 2018 - Objective This guideline provides evidence-based recommendations on treating patients who present with dysphonia, which is characterized by altered vocal quality, pitch, loudness, or vocal effort that impairs communication and/or quality of life. ...

Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recomme...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242215
Plastic and Reconstructive Surgery; Sundaram H, Liew S et. al.

Apr 28th, 2016 - Combination of fillers and botulinum toxin for aesthetic applications is increasingly popular. Patient demographics continue to diversify, and include an expanding population receiving maintenance treatments over decades. A multinational panel of ...

Management of neck pain and associated disorders: A clinical practice guideline from th...
https://doi.org/10.1007/s00586-016-4467-7
European Spine Journal : Official Publication of the Euro... Côté P, Wong JJ et. al.

Mar 18th, 2016 - To develop an evidence-based guideline for the management of grades I-III neck pain and associated disorders (NAD). This guideline is based on recent systematic reviews of high-quality studies. A multidisciplinary expert panel considered the evide...

EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary trac...
https://doi.org/10.1016/j.eururo.2013.03.004
European Urology; Oelke M, Bachmann A et. al.

Apr 2nd, 2013 - To present a summary of the 2013 version of the European Association of Urology guidelines on the treatment and follow-up of male lower urinary tract symptoms (LUTS). We conducted a literature search in computer databases for relevant articles pub...

Botulinum toxin assessment, intervention and after-care for lower limb spasticity in ch...
https://doi.org/10.1111/j.1468-1331.2010.03126.x
European Journal of Neurology; Love SC, Novak I et. al.

Jul 17th, 2010 - Botulinum neurotoxin type-A (BoNT-A) has been used in association with other interventions in the management of spasticity in children with cerebral palsy (CP) for almost two decades. This consensus statement is based on an extensive review of the...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  819 results

Intra-muscular Botulinum Toxin A in Chronic Athletic Pubalgia: a Retrospective Observational Study
https://clinicaltrials.gov/ct2/show/NCT05430893

Jun 24th, 2022 - The investigators included consecutive individuals with chronic athletic pubalgia for whom medical and/or surgical treatments have failed and who were treated with an intra-muscular injection of botulinum toxin A under ultrasound guidance. Partici...

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
https://clinicaltrials.gov/ct2/show/NCT05248867

Jun 24th, 2022 - Facial lines that develop from repeated facial expression, such as glabellar lines (GL), are typically treated by selectively weakening specific muscles with small quantities of botulinum toxin. AGN-151586 is an investigational product being devel...

Botulinum Toxin for the Treatment of Involuntary Movement Disorders
https://clinicaltrials.gov/ct2/show/NCT00001208

Jun 24th, 2022 - The efficacy of botulinum toxin (BTX) has now been demonstrated for a variety of diseases associated with involuntary muscles spasms or movement. The application of botulinum toxin therapy to movement disorders requires treatment tailored to the i...

50% Effective Concentration of Sevoflurane for Immobility
https://clinicaltrials.gov/ct2/show/NCT03553446

Jun 23rd, 2022 - All anesthetics were administered by a single experienced anesthesiologist. Anesthetic induction was performed progressively with inhaled 1-8% sevoflurane, if the patient was cooperative, otherwise directly to the 8%, and subsequent maintenance 2%...

A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines
https://clinicaltrials.gov/ct2/show/NCT05248880

Jun 23rd, 2022 - Facial lines that develop from repeated facial expression, such as glabellar lines (GL), are typically treated by selectively weakening specific muscles with small quantities of botulinum toxin. AGN-151586 is an investigational product being devel...

see more →

News  331 results

Adhesive Tape to Guide Injection Depth of Botulinum Toxin for Axillary Hyperhidrosis
https://www.mdedge.com/dermatology/article/255261/aesthetic-dermatology/adhesive-tape-guide-injection-depth-botulinum-toxin
Jamison A. Harvey, MD, David L. Swanson, MD

Jun 7th, 2022 - Practice Gap OnabotulinumtoxinA is a US Food and Drug Administration–approved second-line treatment of axillary hyperhidrosis, with a long-term success rate greater than 80% and minimal adverse effects. 1 The recommended depth and angle of injectio.

Double the Pleasure: Stim Patch Delays Early Ejaculation: Study
https://www.medscape.com/viewarticle/974773

May 27th, 2022 - A wearable patch that delivers electrical stimulation to the perineum may postpone premature ejaculation, according to research presented at the 2022 annual meeting of the American Urological Association. The disposable device appears to work by h...

20th anniversary and history of cosmetic botulinum toxin type A
https://www.mdedge.com/dermatology/article/254808/aesthetic-dermatology/20th-anniversary-and-history-cosmetic-botulinum
Naissan O. Wesley, MD

May 20th, 2022 - Historical food-borne outbreaks of botulism and identification of Clostridium botulinum as the bacterium responsible have had an enormous impact in medicine related to its therapeutic and cosmetic uses. The timeline of botulinum toxin discovery be.

When the evidence suggests that placebo is best
https://www.mdedge.com/familymedicine/article/248817/musculoskeletal-disorders/when-evidence-suggests-placebo-best
MDedge Family Medicine; John Hickner, MD, MSc, Richard Guthmann, MD, MPH

Nov 17th, 2021 - In this issue of JFP, the Clinical Inquiry seeks to answer the question: What are effective injection treatments for lateral epicondylitis? Answering this question proved to be a daunting task for the authors. The difficulty lies in answering this.

Botulinum toxin for chronic pain: What's on the horizon?
https://www.mdedge.com/familymedicine/article/248633/musculoskeletal-disorders/botulinum-toxin-chronic-pain-whats-horizon
MDedge Family Medicine; Caleb Dickison, DO, CAQSM, Jeffrey C. Leggit, MD, CAQSM

Nov 12th, 2021 - Botulinum toxin (BoNT) was first approved by the US Food and Drug Administration (FDA) for the treatment of strabismus and blepharospasm in 1989. Since then, approved indications have expanded to include spasticity, cervical dystonia, severe axill.

see more →

Patient Education  11 results see all →